cGMP Cell Banking For Cell & Gene Therapy And Biologics

In cell and gene therapy development, a cell bank is far more than a simple repository of starting material—it establishes the baseline for long-term product quality, process consistency, and regulatory viability. Scaling up from research to clinical or commercial manufacturing demands scientifically robust processes that minimize contamination risk while ensuring structural homogeneity. Managing highly variable cell expansion rates and precise doubling times requires flexible operational workflows and specialized infrastructure designed to maintain strict biological integrity.

Utilizing an integrated approach to manufacturing and characterization ensures that critical components, such as Master Cell Banks (MCB) and Working Cell Banks (WCB), are produced under compliant conditions and fully cleared for use. Transitioning seamlessly from validation phases to full production requires specialized aseptic processing, precise environmental control, and a comprehensive battery of release testing—including identity, sterility, and viral safety evaluations. Review our comprehensive cell banking guidelines to discover how an aligned, global testing infrastructure can secure your supply chain and accelerate your therapy's path to market.